Pfizer UK’s Zubair Hussain appointed president-elect of TOPRA
pharmafile | November 27, 2009 | Appointment | Research and Development, Sales and Marketing |Â Â Zubair Hussain, appointment, appointments, research and development, sales and marketing, topraÂ
Pfizer UK’s Zubair Hussain has been appointed president-elect of global regulatory affairs organisation TOPRA.
His appointment was part of a handful of changes to the organisation’s board that also saw Sanofi-Aventis’ Carlos Langezaal made TOPRA’s North American representative and Eisai’s Angela Miller appointed a director.
The appointees were elected the organisation’s Annual General Meeting in Sweden in October and will work to set the body’s strategic direction.
They join a board that combines international expertise with a range of experience from major pharma, consulting firms and independents.
Related Content

Charity commits £800,000 to AI research into late breast cancer recurrence
Breast Cancer Now is investing £800,000 in two research projects using artificial intelligence to investigate …

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025
The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

AAX Biotech announces collaboration for cardiovascular antibody therapy
Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of …






